Astera Labs (NASDAQ:ALAB) Trading 1.8% Higher – Here’s What Happened

Astera Labs, Inc. (NASDAQ:ALAB)’s share price shot up 1.8% during trading on Tuesday . The stock traded as high as $289.60 and last traded at $282.65. Approximately 1,794,787 shares were traded during mid-day trading, a decline of 67% from the average session volume of 5,420,721 shares. The stock had previously closed at $277.53.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on ALAB shares. Barclays lifted their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. TD Cowen cut their target price on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. Evercore reiterated an “outperform” rating and set a $297.00 target price on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Citigroup reaffirmed a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Astera Labs currently has an average rating of “Moderate Buy” and a consensus price target of $333.00.

Astera Labs Stock Up 1.8%

The company has a 50 day simple moving average of $350.46 and a two-hundred day simple moving average of $246.41. The company has a market capitalization of $49.04 billion, a P/E ratio of 139.93 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue was up 104.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In other news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This represents a 9.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of the business’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director owned 75,688 shares in the company, valued at $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 419,244 shares of company stock worth $163,135,169. Company insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Large investors have recently modified their holdings of the company. Royal Bank of Canada increased its position in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after acquiring an additional 95,409 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after buying an additional 7,756 shares during the last quarter. Empowered Funds LLC boosted its stake in Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after buying an additional 4,183 shares in the last quarter. First Trust Advisors LP grew its holdings in shares of Astera Labs by 102.0% during the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares during the last quarter. Finally, Brown Advisory Inc. boosted its stake in Astera Labs by 54.9% in the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.